Equillium Inc banner

Intrinsic Value

The intrinsic value of Equillium Inc (EQ) under the Base Case is 0.1 USD per share. Compared with the current market price of 1.36 USD, the stock appears Overvalued by 92% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

EQ Intrinsic Value
$0.1
Overvaluation 92%
Intrinsic Value
Price $1.36

EQ is more expensive than usual. It was this expensive or more expensive on just 16% of days in the past 5 years.

Monitor EQ
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.08
Get notified when the price drops into your buy zone
Current Price $1.36
Intrinsic Value $0.1
Margin of Safety 20% $0.08
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to EQ

Fundamental Analysis

What Equillium Does

Biotechnology Health Care

Equillium is a clinical-stage biopharmaceutical company that develops medicines for severe autoimmune and inflammatory diseases. Its main focus is on drugs that calm an overactive immune system, especially in conditions where the body attacks its own tissues or causes dangerous inflammation.

Headquarters
United States of America US
Employees
15
IPO date
Oct 12, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Equillium Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

EQ Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one EQ stock?

The intrinsic value for Equillium Inc (EQ) under the Base Case is 0.1 USD.

Is EQ stock undervalued or overvalued?

Compared with the current market price of 1.36 USD, the stock appears Overvalued by 92% .

Back to Top